You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mineralocorticoid

Showing 1 - 25 of 362
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Aldosteronism Trial in Montréal (Renin measurements)

Not yet recruiting
  • Primary Aldosteronism
  • Renin measurements
  • Montréal, Quebec, Canada
    Hôpital du Sacré-Coeur de Montréal
Oct 30, 2023

Primary Hyperaldosteronism Due to Adrenal Adenoma Trial in Gothenburg, Stockholm, Umeå (Unilateral adrenalectomy, Medical

Not yet recruiting
  • Primary Hyperaldosteronism Due to Adrenal Adenoma
  • Unilateral adrenalectomy
  • Medical treatment (eplerenone)
  • Gothenburg, Sweden
  • +2 more
Mar 30, 2023

Renin Angiotensin Aldosterone System Genetic Polymorphism on

Recruiting
  • Myocardial Infarction
    • Cairo, Egypt
      Ain Shams University
    May 16, 2023

    Heart Failure Trial (Finerenone, Placebo)

    Not yet recruiting
    • Heart Failure
    • (no location specified)
    Sep 11, 2023

    s to Learn More About Treatment With Steroidal Mineralocorticoid

    Active, not recruiting
    • Chronic Kidney Disease
    • +2 more
    • sMRA therapies
    • Whippany, New Jersey
      Many Locations
    Jan 30, 2023

    Chronic Kidney Disease, Albuminuria Trial in Birmingham (Spironolactone, Amiloride)

    Completed
    Has Results
    • Chronic Kidney Disease
    • Albuminuria
    • Birmingham, Alabama
      Hypertension Research Clinic at UAB
    Nov 21, 2022

    Atherosclerosis Trial in Cleveland (Spironolactone, Placebo)

    Completed
    • Atherosclerosis
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center
    Sep 16, 2022

    Hypertension, Left Ventricular Hypertrophy Trial (Eplerenone, Chlorthalidone, Potassium)

    Not yet recruiting
    • Hypertension
    • Left Ventricular Hypertrophy
    • (no location specified)
    Oct 26, 2022

    Chronic Kidney Diseases Trial (Mineralocorticoid receptor antagonist, Placebo)

    Not yet recruiting
    • Chronic Kidney Diseases
    • Mineralocorticoid receptor antagonist
    • Placebo
    • (no location specified)
    Sep 21, 2023

    Metabolic Syndrome, Hypertension, Overweight and Obesity Trial in Boston (Eplerenone, Chlorthalidone with potassium chloride)

    Recruiting
    • Metabolic Syndrome
    • +2 more
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Feb 28, 2022

    Hypertension Trial in Ann Arbor (Placebo, Eplerenone 50mg)

    Not yet recruiting
    • Hypertension
    • Placebo
    • Eplerenone 50mg
    • Ann Arbor, Michigan
      University of Michigan
    Feb 4, 2022

    Primary Aldosteronism, Hypertension Trial (Finerenone, Spironolactone)

    Not yet recruiting
    • Primary Aldosteronism
    • Hypertension
    • (no location specified)
    Apr 3, 2023

    Primary Aldosteronism, Resistant Hypertension, Secondary Hypertension Trial in Boston (Best Practice Advisory Computerized

    Not yet recruiting
    • Primary Aldosteronism
    • +5 more
    • Best Practice Advisory Computerized Alert
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jun 22, 2023

    Heart Failure With Reduced Ejection Fraction Trial in New Haven (Best Practice Alert)

    Recruiting
    • Heart Failure With Reduced Ejection Fraction
    • Best Practice Alert
    • New Haven, Connecticut
      Cardiology/Internal Medicine Outpatient Clinics of Yale New Heal
    Jan 17, 2022

    COVID-19, ARDS Trial in Cairo (Fludrocortisone Acetate 0.1 MG)

    Completed
    • COVID-19
    • ARDS
    • Fludrocortisone Acetate 0.1 MG
    • Cairo, Abbasia, Egypt
      Ain Shams University
    Jul 9, 2022

    Hypertension, Mineralocorticoid Excess Trial in Boston (Eplerenone, Amlodipine)

    Recruiting
    • Hypertension
    • Mineralocorticoid Excess
    • Boston, Massachusetts
      Brigham and Women's
    Jul 20, 2022

    HIV Trial in Boston (Eplerenone, Placebo, Lifestyle Modification)

    Completed
    • HIV
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jul 14, 2022

    Kidney Transplantation for More Than One Year, Patients With a Kidney Transplantation on Cyclosporine Trial in

    Recruiting
    • Kidney Transplantation for More Than One Year
    • Patients With a Kidney Transplantation on Cyclosporine
    • Eplerenone 50mg/day (cross over design)
    • Period without eplerenone (cross over design)
    • Vandœuvre-lès-Nancy, France
      CHRU de Nancy
    Aug 17, 2022

    Heart Failure Trial in Worldwide (Spironolacton)

    Completed
    • Heart Failure
    • Corbeil-Essonnes, France
    • +8 more
    Mar 7, 2022

    COVID-19 Pneumonia Trial in Szczecin (Canrenoate Potassium, Normal Saline)

    Recruiting
    • COVID-19 Pneumonia
    • Canrenoate Potassium
    • Normal Saline
    • Szczecin, Poland
      Pomeranian Medical University
    Jun 3, 2021

    Heart Failure, Type 2 Diabetes, Glucose Intolerance Trial in Montreal (Eplerenone, Spironolactone)

    Completed
    • Heart Failure
    • +2 more
    • Montreal, Quebec, Canada
      Montreal Heart Institute
    Oct 5, 2022

    Chronic Kidney Diseases, Heart Failure With Reduced Ejection Fraction, Hyperkalemia Trial in London (Lokelma Oral Product)

    Recruiting
    • Chronic Kidney Diseases
    • +4 more
    • Lokelma Oral Product
    • London, United Kingdom
      St Georges, University of London
    Feb 16, 2022

    Outcome of Patients With Primary Aldosteronism

    Recruiting
    • Primary Aldosteronism
    • +8 more
    • Unilateral adrenalectomy in patients with unilateral disease
    • Singapore, Singapore
      Changi General Hospital
    Aug 10, 2021

    Primary Aldosteronism, Hypertension Trial (Eplerenone)

    Not yet recruiting
    • Primary Aldosteronism
    • Hypertension
    • (no location specified)
    Aug 26, 2021

    Vitreomacular Traction, Subretinal Edema Trial in Norfolk (Eplerenone)

    Terminated
    • Vitreomacular Traction
    • Subretinal Edema
    • Norfolk, Virginia
      Wagner Macula & Retina Center
    Jan 6, 2021